Nemdx’s Breakthrough in ALS Detection Garnering Attention

Nemdx Inc.’s pioneering work in early ALS detection is garnering attention in the medical community. By collaborating with leading research centers, the company’s innovative assays are shedding light on potential biomarker candidates associated with ALS. This breakthrough holds promise for more accurate diagnosis and targeted therapies for ALS patients.

Share This Post

Scroll to Top